Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
mRNA-decapping enzyme 1B (DCP1B) is a human protein encoded by the DCP1B gene, functioning as a core component of the mRNA decapping complex responsible for 5’ cap removal from messenger RNA[5][6][3]. This enzyme acts within cytoplasmic foci, termed P-bodies, which serve as sites for mRNA turnover and degradation[4]. DCP1B is involved in both normal mRNA turnover and nonsense-mediated mRNA decay, and it plays a critical role in regulating mRNA stability, thereby impacting post-transcriptional gene expression[1][2][3]. It interacts with other decapping factors (most notably DCP2) and acts as a platform enhancing mRNA-binding affinity of the decapping catalytic subunit, DCP2[1]. Its biological function appears to partly overlap with its paralog DCP1A; both are functionally redundant with distinct roles in specific endogenous mRNA regulation[1]. Current literature does not support any direct association with major disease pathophysiology or targeted therapeutics; drug interaction and biomarker relevance have not been demonstrated[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mRNA-decapping enzyme 1B (DCP1B).